April 8, 2020 Licensing, IP, and Legal Liq. Handling & Robotics

Brooks to Participate in the 19th Annual Needham Virtual Healthcare Conference

CHELMSFORD, Mass., April 8, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in the 19th Annual Needham Virtual Healthcare Conference on Tuesday, April 14, 2020 at 10:40 a.m. ET.  The 40-minute session will be webcast live via the Brooks investor relations website at www.brooks.investorroom.com/events. About Brooks AutomationBrooks (Nasdaq: BRKS)... Read more

April 7, 2020 Licensing, IP, and Legal

Roche provides regulatory update on risdiplam for the treatment of spinal muscular atrophy (SMA)

U.S. Food and Drug Administration (FDA) extends review time for risdiplam following agreed submission of additional data, including SUNFISH Part 2 Roche has submitted filing applications for risdiplam in seven countries with submission in China imminent Risdiplam is being investigated in infants, children and adults with Type 1, 2 or 3 SMA Basel, 07 April... Read more

March 23, 2020 Bio/Pharma/CRO Lab Top-10 Licensing, IP, and Legal PR/Corporate

Thermo Fisher Scientific Continues Investments to Accelerate Biopharma Commercialization

Thermo Fisher Scientific Continues Investments to Accelerate Biopharma Commercialization Capabilities and capacity now available to help customers of all sizes meet increasing demand for new biologics, cell and gene therapies, and drug products NEEDHAM, Mass., March 23, 2020 /PRNewswire/ — For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug... Read more

March 18, 2020 Licensing, IP, and Legal Life Science Tools PAI Top-10

Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore Technologies

MENLO PARK, Calif., March 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not overall favorable for Pacific Biosciences, but mixed in terms of its findings.... Read more

March 16, 2020 Licensing, IP, and Legal

Roche Annual General Meeting 2020: Voting will take place by independent proxy. Participation on site is neither possible nor permitted by Federal Council ordinance

The Roche Annual General Meeting 2020 will be held under conditions of the COVID-19 Ordinance 2 of the Federal Council To comply with regulatory requirements, voting at the AGM will be by independent proxy Shareholders who are physically present will be able to cast their votes through the proxy, but will not be admitted to... Read more

March 3, 2020 Licensing, IP, and Legal M&A, Partnerships Product Launch

JEOL USA highlights new strategic partnerships strengthening its position as world-leading instrument provider

2 March 2020, PEABODY, MA:  JEOL USA, a leader in developing instruments used to advance scientific research and technology, is pleased to highlight its latest key strategic partnerships at Pittcon 2020: Mass-Spectrometry: NETZSCH integrated Thermal Analysis GC/MS system Electron Microscopy: Acquisition of Integrated Dynamic Electron Solutions, Inc. NMR Spectroscopy: RIKEN-JEOL Collaboration Center and the Kyoto... Read more

March 2, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

GE Healthcare completes transfer of ownership of its four diagnostic imaging agents from Daiichi Sankyo

Tokyo, Japan and Chicago, US (March 2nd, 2020) – GE Healthcare (Head Office: Chicago, US) today completed the transfer of ownership of its four diagnostic imaging agents in Japan from Daiichi Sankyo Company, Limited (Head Office: Chuo-ku Tokyo; Daiichi Sankyo). Effective immediately, the four imaging agents, previously managed by Daiichi Sankyo, will be owned and... Read more

February 27, 2020 Licensing, IP, and Legal Life Science Tools PAI Top-10

Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit relating to BGI’s “CoolMPS” sequencing products. The complaint was filed against BGI Genomics Co., Ltd., BGI Americas Corp., MGI Tech Co., Ltd., MGI Americas, Inc. and Complete Genomics Inc. in the United States District Court for the Northern District... Read more

February 26, 2020 Chemicals, Reagents & Kits Licensing, IP, and Legal

QIAGEN announces worldwide shipments of QIAstat-Dx test kits for SARS-CoV-2

Hilden, Germany, and Germantown, Maryland, February 26, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has shipped its newly developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation. The new kit detects the novel coronavirus SARS-CoV-2 and adds rapid Sample to Insight syndromic testing to QIAGEN’s... Read more

February 13, 2020 Atomic Spectroscopy Licensing, IP, and Legal

Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020

AUSTIN, Texas, Feb. 13, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President & CEO, and Harriss Currie, Senior Vice President of Finance and CFO, plan to participate at three investor conferences in March 2020. Morgan Stanley European MedTech & Services Conference in London, England on March 3, 2020: one-on-one investor meetings.... Read more